Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma

Holmang, 1999, Recurrence and progression in low grade papillary urothelial tumours, J Urol, 162, 702, 10.1097/00005392-199909010-00019 Chopin, 2002, Superficial bladder tumours, Eur Urol, 42, 533, 10.1016/S0302-2838(02)00466-9 Laird, 2003, The power and the promise of DNA methylation markers, Nat Rev Cancer, 3, 253, 10.1038/nrc1045 Jones, 2002, The fundamental role of epigenetic events in cancer, Nat Rev Genet, 3, 415, 10.1038/nrg816 Jones, 1999, Cancer epigenetics comes of age, Nat Genet, 21, 163, 10.1038/5947 Friedrich, 2004, Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients, Clin Cancer Res, 10, 7457, 10.1158/1078-0432.CCR-04-0930 Pao, 2001, The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumour cells, Hum Mol Genet, 10, 903, 10.1093/hmg/10.9.903 Chan, 2002, Hypermethylation of multiple genes in tumour tissues and voided urine in urinary bladder cancer patients, Clin Cancer Res, 8, 464 Tada, 2002, The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancers, Cancer Res, 62, 4048 Ribeiro-Filho, 2002, CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer, Mol Carcinog, 34, 187, 10.1002/mc.10064 Horikawa, 2003, Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ, J Urol, 169, 1541, 10.1097/01.ju.0000046242.55722.1c Bornman, 2001, Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals, Am J Pathol, 159, 831, 10.1016/S0002-9440(10)61758-0 Liang, 2000, The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumour cells, Cancer Res, 60, 4907 Esteller, 2001, A gene hypermethylation profile of human cancer, Cancer Res, 61, 3225 Galm, 2003, SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma, Blood, 101, 2784, 10.1182/blood-2002-06-1735 Babidge, 2001, Methylation of CpG sites in exon 2 of the bcl-2 gene occurs in colorectal carcinoma, Anticancer Res, 21, 2809 Devereux, 1999, DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene, Cancer Res, 59, 6087 Vos, 2000, Ras uses the novel tumour suppressor RASSF1 as an effector to mediate apoptosis, J Biol Chem, 275, 35669, 10.1074/jbc.C000463200 Conway, 2000, TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers, Cancer Res, 60, 6236 Arnold, 2001, Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas, Br J Cancer, 85, 1351, 10.1054/bjoc.2001.2075 Bachman, 1999, Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers, Cancer Res, 59, 798 Karpf, 1999, Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumour cells, Proc Natl Acad Sci USA, 96, 14007, 10.1073/pnas.96.24.14007 Eads, 2000, MethyLight: a high-throughput assay to measure DNA methylation, Nucleic Acids Res, 28, E32, 10.1093/nar/28.8.e32 Masferrer, 2000, Antiangiogenic and antitumour activities of cyclooxygenase-2 inhibitors, Cancer Res, 60, 1306 Marrogi, 2000, Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma, Clin Cancer Res, 6, 4739 Miyata, 2003, Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumour cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival, Clin Cancer Res, 9, 1741 Narayan, 2003, Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome, Mol Cancer, 2, 24, 10.1186/1476-4598-2-24 Schneider-Stock, 2003, High prognostic value of p16INK4 alterations in gastrointestinal stromal tumours, J Clin Oncol, 21, 1688, 10.1200/JCO.2003.08.101 Roman-Gomez, 2002, 5′ CpG island hypermethylation is associated with transcriptional silencing of the p21 (CIP1/WAF1/SDI1) gene and confers poor prognosis in acute lymphoblastic leukemia, Blood, 99, 2291, 10.1182/blood.V99.7.2291 Maruyama, 2001, Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features, Cancer Res, 61, 8659 Bindels, 2000, E-cadherin promotes intraepithelial expansion of bladder carcinoma cells in an in vitro model of carcinoma in situ, Cancer Res, 60, 177 Shariat, 2001, E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder, Urology, 57, 60, 10.1016/S0090-4295(00)00892-X Byrne, 2001, E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup, J Urol, 165, 1473, 10.1016/S0022-5347(05)66330-6 Garcia del Muro, 2000, Prognostic value of the expression of E-cadherin and beta-catenin in bladder cancer, Eur J Cancer, 36, 357, 10.1016/S0959-8049(99)00262-2 Solsona, 1999, Effectiveness of a single immediate mitomycin C instillation in patients with low-risk superficial bladder cancer: short and long-term followup, J Urol, 161, 1120, 10.1016/S0022-5347(01)61606-9 Wild, 2003, Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumours, J Clin Endocrinol Metab, 88, 1367, 10.1210/jc.2002-021027 Zochbauer-Muller, 2001, Aberrant promoter methylation of multiple genes in non-small cell lung cancers, Cancer Res, 61, 249